State of the Art in Alzheimer’s Disease Pathology
A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Neurodegenerative Diseases".
Deadline for manuscript submissions: closed (20 January 2024) | Viewed by 276
Special Issue Editor
Special Issue Information
Dear Colleagues,
Alzheimer's disease (AD) is the most common age-related progressive neurodegenerative disorder, and its pathology involves a long preclinical period. The amyloid β (Aβ) peptides, total tau protein (T-tau), and tau protein phosphorylated at threonine 181 (P-tau(181)) are considered surrogate biomarkers of Alzheimer's disease pathology. Despite advances in preclinical and clinical studies of AD in recent years, its pathogenesis is still unclear and effective methods of treatment are lacking. The aim of this Special Issue is to highlight the recent advances in research by collecting original articles and reviews that present the current developments in AD biomarkers, AD pathogenesis, and AD-related therapeutic strategies.
Prof. Dr. Amit Singh
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Alzheimer's disease
- pathology
- amyloid β (Aβ) peptides
- total tau protein
- therapeutic strategies
- amyloid hypothesis
- animal models
- genetic modifiers
- mechanistic insights
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
